Germany · Series B startup

Who invested in Seiratherm

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$378Kraised across 2 rounds since 2012, from 2 sources

Latest round
Series B, $378KJan 2017
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201220132014201520162017
?Round$378KSeries B
First round
Round
Feb 2012
Biggest round
$378K
Series B · Jan 2017
Between rounds
4.8 years
from the last two

The rounds

  1. Jan 2017
    Series B$378K1 returning

    Source recorded

  2. Feb 2012
    RoundAmount undisclosed2 new

    Reported by finsmes.com

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Bayern KapitalGovernment2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Seiratherm

Who invested in Seiratherm?

Seiratherm's investors include Bayern Kapital and High-Tech Gründerfonds.

How much has Seiratherm raised?

Seiratherm has raised $378K across 2 rounds since 2012. One round did not disclose an amount, so the total is a floor.

When did Seiratherm last raise?

Seiratherm's most recent round was a Series B of $378K in Jan 2017.

What was Seiratherm's biggest round?

Its most recent round, $378K in Jan 2017, is also its largest on record.

Who backed Seiratherm first?

Seiratherm's first round on record, in Feb 2012, was backed by High-Tech Gründerfonds and Bayern Kapital.

What stage is Seiratherm at?

Seiratherm's latest named round is a Series B, in Jan 2017.

Where is Seiratherm based?

Seiratherm is based in Germany.

Companies like Seiratherm

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.